Wockhardt Bio is an API manufacturer based in Switzerland. It holds 8 active US drug master files across a filed portfolio of 8 molecules. Its filings concentrate with US FDA and EMA.
| Molecule | Regulators | Docs |
|---|---|---|
| Aripiprazole | US FDA | 1 |
| Fesoterodine | US FDA | 1 |
| Fosaprepitant | US FDA | 1 |
| Paliperidone | US FDA | 1 |
| Palonosetron | US FDA | 1 |
| Regadenoson | US FDA | 1 |
| Saxagliptin | US FDA | 1 |
| Sitagliptin | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | 39 | None |
| EMA | 1 | None |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Wockhardt Bio comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.